SB3878

Illinois SB3878, the 340B Integrity Act, regulates the use of 340B drug discounts by covered entities.

Illinois SB3878, the 340B Integrity Act, mandates that 340B covered entities use 80% of their profits to reduce out-of-pocket costs for low-income patients and the remaining 20% for free and discounted care. Beginning January 1, 2027, these entities cannot bill Medicaid for 340B drugs. The Department of Healthcare and Family Services must report on the impact of foregone rebates, premiums, and out-of-pocket costs. The Department of Insurance will receive annual reports on 340B drug purchases and related costs.